No7 Protect & Perfect ADVANCED Serum, for improving the first signs of ageing that usually starts to appear between 25 and 35 years old.
No7 Protect & Perfect Intense ADVANCED Serum, for improving the appearance of deep lines and wrinkles typically experienced by women aged 35+.
Fuller details on all aspects of the new products and the clinical and consumer trials can be found onwww.No7Serum.co.uk
Now even more powerful: The scientists at No7 have reformulated the proven anti-ageing classic serums for greater anti-ageing power with a new blend of key ingredients carefully chosen for their ability to help repair and protect the skin.
- More powerful repair: with a peptide complex that includes greater quantities of Matrixyl 3000, the star ingredient which drives repair of fibrillin, a structural protein in the skin combined with a new peptide. The concentration of peptides in the No7 Protect & Perfect Intense ADVANCED Serums have now been significantly increased compared to the original serums
- More powerful protection: with a patented antioxidant complex to help protect skin from unstable free radical molecules combined with inhibitors of enzymes that cause break down of structural proteins in ageing skin
To demonstrate how effective the new No7 Protect & Perfect ADVANCED Serums are, the scientists at No7 undertook their most extensive and comprehensive testing programme ever, involving more than 2,600 volunteers, 22 separate studies, including both consumer and clinical trials.
Dr Mike Bell, Skincare Scientific Advisor, Boots UK, comments: “This has been the most rigorous and complex product development phase that we have ever undertaken. The identification of effective anti-ageing solutions has to come from an in-depth understanding of the biology of the ageing process.”
In clinical trials, the new serums were put to the ultimate test - not against a placebo, but against the original, well-proven No7 Protect & Perfect Serums and as a result, the new No7 Protect & Perfect ADVANCED Serums are clinically proven to be even more effective at reducing the appearance of lines and wrinkles.
In consumer trials, designed to show how well the products work in real life, hundreds of women tested our serums. An impressive 80% of them saw their best anti-ageing results ever*. More than eight out of 10 women in the user trials preferred the new No7 Protect & Perfect ADVANCED Serums to their current regime.
Harpenden, a No7 serum user trialling No7 Protect & Perfect ADVANCED Serum
“Fabulous product, I noticed a difference and more importantly, others did.” Helen,
Stafford, a non serum user trialling No7 Protect & Perfect Intense ADVANCED Serum
Dr Mike Bell concludes: “Now we can say that No7 Protect & Perfect ADVANCED Serums are clinically proven to be even more effective. These are the best anti-ageing results we’ve ever seen. Our best just got better.”
No7 Protect & Perfect ADVANCED Serum (£23.95 for 30ml) and No7 Protect & Perfect Intense ADVANCED Serum (£24.95 for 30ml) are exclusively available at Boots stores across the UK and on boots.com from Wednesday 14 May 2014.
For further information, samples, images, expert interviews please call the Boots No7 Media Centre team on 020 7025 6677 or email email@example.com
Notes to editors:
No7 is the UK’s leading skincare brand, available exclusively at Boots. The ambition of No7’s brand campaign is to allow women to tell their story through their own voice, and encourage other women to experience it too. It is a real celebration of British beauty, inspiring women to experience their ‘Ta Dah!’ moment. With no air-brushing or re-touching, the campaign shows the range of positive looks and emotions women can experience.
The No7 team continues to invest in groundbreaking research and development and our international team are responding to the ever changing needs of its millions of customers every day. From No7’s range of clinically proven anti-ageing serums, to the breakthrough No7 Match Made Service, No7 customers believe in the power of our products as much as we do.
About Boots UK
* Figures are approximations as at 31 March 2013 and include associates and joint ventures.